Assignee
THERIPION INC
US·6 granted patents·5 pending applications·7 citations·filing 2018–2025
Top patents by PatentIndex Score
11 records- 0198US12180521B2Paraoxonase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2022·Granted Dec 31, 2024·6 cites·22 claims
- 0293US12258596B2Polynucleotides encoding paraoxonase fusion polypeptidesTHERIPION INC·Filed 2024·Granted Mar 25, 2025·0 cites·24 claims
- 0393US2026062460A1Methods for treating acute coronary syndrome using apoa-1 fusion proteinsTHERIPION INC·Filed 2025·Application pending·0 cites
- 0490US11472864B2Polynucleotides encoding APOA1-PON1 fusion polypeptidesTHERIPION INC·Filed 2021·Granted Oct 18, 2022·1 cites·16 claims
- 0590US2024294889A1Dnase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2024·Application pending·0 cites
- 0682US2023015291A1Dnase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2022·Application pending·0 cites
- 0781US12509501B2Polynucleotides encoding APOA-1 fusion polypeptidesTHERIPION INC·Filed 2025·Granted Dec 30, 2025·0 cites·20 claims
- 0881US2023024372A1Polynucleotides encoding apoa1-rnase fusion polypeptidesTHERIPION INC·Filed 2022·Application pending·0 cites
- 0978US12497604B2RNase-PON1 fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2025·Granted Dec 16, 2025·0 cites·16 claims
- 1075US2025145977A1Methods for treating rheumatoid arthritis using ctla4-pon1 fusion proteinsTHERIPION INC·Filed 2025·Application pending·0 cites
- 1170US12331102B2APOA-1 fusion polypeptides and related compositionsTHERIPION INC·Filed 2018·Granted Jun 17, 2025·0 cites·30 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →